Abeona says it will start Sanfilippo B gene therapy trial in Q2 – FierceBiotech
FierceBiotech |
Abeona says it will start Sanfilippo B gene therapy trial in Q2
FierceBiotech Abeona Therapeutics announced it is just weeks away from enrolling the first patients in a trial of its gene therapy for the lysosomal storage disease Sanfilippo B. The new comes as the gene therapy candidate—called ABO-101—has just been awarded … |
